Navigation Links
SCAI announces 2009 annual scientific sessions in Las Vegas
Date:5/15/2008

WASHINGTON, D.C. -- May 15, 2008 -- The Society for Cardiovascular Angiography and Interventions (SCAI) today announced that it will hold its 2009 Annual Scientific Sessions May 6-9, 2009, at Caesars Palace, Las Vegas. The focused, collegial interventional cardiology meeting will move to a late February or early March meeting time beginning in 2010.

The 2009 SCAI Annual Scientific Sessions will be the premier interventional cardiology meeting of the spring for practicing interventional cardiologists, said Ziyad M. Hijazi, M.D., MPH, FSCAI, president of SCAI. Our focused meeting will emphasize the latest scientific advances in coronary, peripheral and structural heart disease.

SCAI has been known for its signature Best of the Best in Interventional Cardiology meeting, and our more intimate, collegial format, said Bonnie H. Weiner, M.D., MSEC, MBA, FSCAI, immediate past president of SCAI. We look forward to building on our strong 32-year tradition in 2009 and moving to an earlier meeting in 2010.

The 2009 meeting will feature current and cutting-edge interventional science, emphasizing evidence-based medicine and clinical trial data that interventionalists can translate into daily practice. The meeting will be chaired by Ted Feldman, M.D., FSCAI, past president of SCAI, director of the cardiac catheterization laboratory at Evanston Hospital and a professor of medicine at Northwestern University Medical School in Chicago. Dr. Feldman will be joined by a team of interventional cardiologists to develop an educational program featuring new clinical trials, case-based education and analysis of advances in coronary, vascular and peripheral diseases, as well as pediatric and structural heart disease.

Our 2009 meeting will focus on the latest news and education that practicing interventional cardiologists can take back and apply to their daily practices, said Dr. Feldman. The 2009 SCAI Annual Scientific Sessions will bring together th
'/>"/>

Contact: Kathy Boyd David
pr@scai.org
717-422-1181
Society for Cardiovascular Angiography and Interventions
Source:Eurekalert

0

GOOD

Page: 1 2

Related medicine news :

1. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
2. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
3. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
4. HEI, Inc. Announces Sale of RFID Division Assets
5. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
6. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
7. Z Trim Announces Revocation of Gregory Halpern Severence Agreement
8. Brooke Franchise Corporation Announces Selected July Results
9. Manor Care, Inc. Announces Record Date for Special Stockholder Meeting
10. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
11. Planet Technologies Announces Agreement to Acquire Antigen Laboratories
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/10/2008)...ng point for behavior change, DES MOINES, Iowa, O...,Americans (51 percent) believe there are good thi...r changes are needed, according to the 2008,EBRI H...oday by the,Employee Benefit Research Institute an...derwritten by the Principal Financial Group(R)., ...
(Date:10/10/2008)...dentialing Center (ANCC) has designated Geisinger ...s came via a conference call to hospital administr...and applause., GMC joins an elite group of only 1...n the United States that have achieved Magnet stat...s recognition., "Achieving Magnet designation is ...
(Date:10/10/2008)... blame , , FRIDAY, Oct. 10 (HealthDay Ne...ve diabetes, being depressed was associated with a..., Publishing in the October issue of the Journal...he University of Washington tracked 10,704 Medicar...d diabetes and were enrolled in a disease manageme...
(Date:10/10/2008)...llence in the implementation of electronic health ...agement Systems Society (HIMSS) announces the reci...onal, Ambulatory and Community Health Organization...L (PRWEB) October 10, 2008 -- Honoring excellence ... (EHRs), the Healthcare Information and Managemen...
Breaking Medicine News(10 mins):Health News:Video: Just What the Doctor Ordered: Survey Shows Americans Adopting Healthier Lifestyles 2Health News:Video: Just What the Doctor Ordered: Survey Shows Americans Adopting Healthier Lifestyles 3Health News:Geisinger Medical Center earns prestigious Magnet designation 2Health News:Older Diabetics With Depression Face Higher Death Rate 2Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 2Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 3Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 4Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 5
...versity of Pennsylvania report the first ever use ... multiple body organs.// Mucopolysaccharidosis VII... called lysosomal storage diseases. Other examples...PS involves an enzyme defect, leading to blindness...
...e new high-tech abortion drug being freely sold ov...f do-it-yourself-abortions,// experts fear. Alread...tives, they claim, and even as the pharmaceutical ...ar meals ostensibly to introduce them to “the revo...
...gh discovery, American researchers have found some...pond to stimuli in the womb. There have always bee...mens such as 'hothousing',// where the baby is rea...he womb. However, the effectiveness of inventions...
...emical Laboratory (NCL) and Emcure Pharmaceuticals...ith a new drug for the treatment of hypertension. ...sday,// NCL director Sivaram and Emcure managing d...odipine, a product of their collaborative research...
Other Medicine News:Health News:Abortion made easy pill causes alarm in state 2
(Date:10/8/2008)..., France, Oct. 8 /- Vical Incorporate...inical data and new nonclinical data,demonstrating...roadly,applicable in DNA- and protein-based infect...cines. Alain P. Rolland, Pharm.D., Ph.D., Vical,s,... present the data today,Wednesday, October 8, at ...
(Date:10/7/2008)...aluates the efficacy of new device for detecting p...ing colonoscopy, ORLANDO, Fla., Oct. 7 /PRNewswir...Annual Scientific Meeting in Orlando (ACG 2008), r...ented results from a,multi-institutional clinical ...(R) Retroscope(R), a new device that is designed t...
(Date:10/7/2008)...Showed Larazotide Acetate Prevented Immunologic Ch...s with Celiac Disease, Additional Data Indicates P...ORLANDO, Fla., Oct. 7 /- Alba Therape...cal studies this week at the American,College of G...ng. Data from,study CLIN 1001-004, the first Phase...
(Date:10/7/2008)... - Data Presented Today at ACG Annual Scientific M...Call/ -- Ironwood,Pharmaceuticals, Inc. (formerly ...E: FRX ) today announced the presentation of resu...safety and efficacy in 420 patients with,irritable...s of the data,indicates that once- daily oral dosi...
Breaking Medicine Technology:Vical Expands Applications of Vaxfectin(R) Adjuvant for Infectious Disease and Cancer Vaccines; 80% to 100% of High-Dose Responders in H5N1 Clinical Trials Still Responding at 6 Months 2Vical Expands Applications of Vaxfectin(R) Adjuvant for Infectious Disease and Cancer Vaccines; 80% to 100% of High-Dose Responders in H5N1 Clinical Trials Still Responding at 6 Months 3Vical Expands Applications of Vaxfectin(R) Adjuvant for Infectious Disease and Cancer Vaccines; 80% to 100% of High-Dose Responders in H5N1 Clinical Trials Still Responding at 6 Months 4Vical Expands Applications of Vaxfectin(R) Adjuvant for Infectious Disease and Cancer Vaccines; 80% to 100% of High-Dose Responders in H5N1 Clinical Trials Still Responding at 6 Months 5National Study Presented at ACG 2008 Confirms New Device Functions Like 'Rear-View Mirror' to Provide Improved View of the Colon 2National Study Presented at ACG 2008 Confirms New Device Functions Like 'Rear-View Mirror' to Provide Improved View of the Colon 3National Study Presented at ACG 2008 Confirms New Device Functions Like 'Rear-View Mirror' to Provide Improved View of the Colon 4National Study Presented at ACG 2008 Confirms New Device Functions Like 'Rear-View Mirror' to Provide Improved View of the Colon 5Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 2Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 3Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 4Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 5Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 6Ironwood and Forest Present Positive Phase 2b Study Results for Linaclotide in Patients With Irritable Bowel Syndrome With Constipation 2Ironwood and Forest Present Positive Phase 2b Study Results for Linaclotide in Patients With Irritable Bowel Syndrome With Constipation 3Ironwood and Forest Present Positive Phase 2b Study Results for Linaclotide in Patients With Irritable Bowel Syndrome With Constipation 4Ironwood and Forest Present Positive Phase 2b Study Results for Linaclotide in Patients With Irritable Bowel Syndrome With Constipation 5AMERIGROUP Corporation to Host Investor Day 1320 1AMERIGROUP Corporation to Host Investor Day 1320 2Amylin Pharmaceuticals to Webcast Corporate Overview During 43rd Annual Meeting of the European Association for the Study of Diabetes 1317 1Monsanto Company Signs Share Subscription Agreement With Devgen 594 1Monsanto Company Signs Share Subscription Agreement With Devgen 594 2Monsanto Company Signs Share Subscription Agreement With Devgen 594 3Non Stick Gum Something to Chew On 1313 1
0.5 mm, 1 x 2 teeth set at 45 degrees and 6 mm tying platform. Serrated handle with polished finish.
5 mm tying platform, serrated cross action handle with polished finish. Teeth: 0.10 mm, 1 x 2 set at 90 degrees.
Colibri style tips with 0.12 mm, 1 x 2 teeth. Round knurled handle with alignment pin and polished finish.
0.12 mm, 1 x 2 teeth set at 45 degrees with 6 mm tying platform. Wide serrated handle with polished finish.
Medicine Products: